NHS nod for Celadon cannabis medicine trial
The approval involves the roll-out of a non-cancer chronic pain study for up to 5,000 patients
Read More
Tag: cannabis
Cannabis firm launches UK clinic following prescription license allocation
Cantourage has appointed cannabis prescribers and is now officially operational via a new centre
Read More
NICE highlights need for more cannabis-based research
NHS England has also published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products.
Read More
First UK medical cannabis clinic launched by specialist doctors
The clinic will offer access to medicinal cannabis for all conditions acknowledged to benefit from it.
Read More
ECH makes moves toward facilitating medical cannabis importation in UK, EU
Astral Health will act as a gateway to the European cannabis market.
Read More
Althea to launch cannabis based products in the UK
Althea, the Australian medicinal cannabis company, has launched in the UK, following changes allowing specialist doctors to prescribe cannabis-based products for medicinal use to certain patients.
Read More
UK doctors allowed to prescribe medical cannabis from November
From November 1 specialist clinicians in the UK will be able to prescribe cannabis-derived medicinal products for the first time after a change in the law, the Home Office has confirmed.
Read More
UK drug advisors recommend rescheduling of medical cannabis
Clinicians in the UK should have the option to prescribe cannabis-derived medicinal products where appropriate, drug experts have concluded, paving the way for laws prohibiting their use to be relaxed.
Read More
Cannabis-based meds beneficial for some conditions, finds UK review
The UK’s chief medical officer and advisor Professor Dame Sally Davies has concluded that there is evidence to show the therapeutic benefit of cannabis-based medicines for some conditions.
Read More
UK announces review of medicinal cannabis
Home secretary Sajid Javid has announced a review of medicinal cannabis in the UK, in response to growing pressure to allow use of cannabis oil to help control seizures in children with severe forms of epilepsy.
Read More
GW planing to test its cannabinoids in cancer
GW Pharma is strengthening its focus on oncology after promising mid-stage data for its cannabis-based therapy in patients with a rare and aggressive brain tumour called glioblastoma multiforme (GBM).
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
